⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL175725 | 0.73 | MGLL (0.42) | — | |
| SCHEMBL515246 | 0.71 | — | — | |
| SCHEMBL2571475 | 0.69 | — | — | |
| SCHEMBL2922210 | 0.69 | — | — | |
| SCHEMBL4978013 | 0.66 | GAA (0.31) | — | |
| SCHEMBL28365068 | 0.65 | MGLL (0.35) | — | |
| SCHEMBL22015479 | 0.65 | MGLL (0.35) | — | |
| SCHEMBL5881151 | 0.63 | MGLL (0.46) | — | |
| SCHEMBL1817414 | 0.63 | MGLL (0.36) | — | |
| SCHEMBL9193351 | 0.63 | GAA (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016196910-A1 | COMPOUNDS FOR THE MODULATION OF MYC ACTIVITY | SYROS PHARMACEUTICALS, INC. (US) | 2016-12-08 | — | — | WO | disclosed |
| WO-2016197078-A1 | COMPOUNDS FOR THE MODULATION OF MYC ACTIVITY | SYROS PHARMACEUTICALS, INC. (US) | 2016-12-08 | — | — | WO | disclosed |